Work

Biomarker Signatures Correlate with Clinical Outcome in Refractory Metastatic Colorectal Cancer Patients Receiving Bevacizumab and Everolimus

Year: 2015

Type: article

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.mct-14-0923-t

Authors: Yingmiao Liu, Mark D. Starr, John C. Brady, Christel Rushing, Anuradha Bulusu, Herbert Pang, Wanda Honeycutt, Anthony Amara, Ivy Altomare, Hope E. Uronis, Herbert I. Hurwitz, Andrew B. Nixon

Institutions: Duke University, Duke Medical Center, University of Hong Kong

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Genentech

OpenAlex ID: W2113058482

FWCI: 0.728

Cites: 45

Cited by: 24

Related to: 10